1. HBW Insight
  2. >>Wellness
  3. >>Policy & Regulation
  4. >>Legislation

Using Pre-Tax Savings Accounts For Supplements Proposed In Senate Budget Reconciliation

 
• By Malcolm Spicer

Republicans in Senate voted against majority Democrat’s proposal to use budget reconciliation for passing pandemic relief legislation, but two GOP members introduced amendment for buying supplements with HSAs because the process is an opportunity to introduce proposals not directly related economic stimulus.

United States Capitol Building in Washington DC USA

Republicans added to the US Senate’s budget reconciliation process for passing another COVID-19 relief bill an amendment that would make dietary supplements eligible for purchases with pre-tax health savings accounts.

Although Republicans in the Senate voted against the majority Democrats’ proposal to use budget reconciliation for passing pandemic relief legislation,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

Utah Delegation’s Support For Supplement Industry Key For Caucus Restart In Congress

 
• By Malcolm Spicer

Dietary Supplement Caucus e-launched the 119th Congress with Utah Republican House member Mike Kennedy and Texas Democrat member Marc Veasey as co-chairs and with a total of nine senators and 20 House members spanning both parties.

Price To Resolve US Hemp Dilemma Too High In House Appropriators’ FY 2026 FDA Spending Bill

 
• By Malcolm Spicer

Provisions in bill approved by Agriculture, Rural Development, FDA and Related Agencies Subcommittee aren’t likely to pass largely because they set a price too high for delta-8 THC and other ingredients to meet the definition of hemp as a de-scheduled substance.

House Appropriators’ $3.2Bn For FDA In FY 2026 Includes More Non-User Fee Funds Than Requested

 
• By Sue Sutter and Derrick Gingery

A US House bill would give the FDA $33.1m more in budget authority than requested by the Trump Administration for fiscal year 2026. The measure was sent to the full House Appropriations committee on a party-line vote.

CHPA Survey Shows Consumer Trust In Supplements Strong, Not So Much In Regulation

 
• By Malcolm Spicer

Results of survey found a majority of representative sample of US voters nationwide agree “current regulations should be updated and strengthened to protect consumers,” CHPA says.

More from Policy & Regulation